Assessing the Value of Antipsychotics for Treating Schizophrenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessing the Value of Antipsychotics for Treating Schizophrenia

Published:2004 Issue:1 Volume:22 Page:1-8
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Tunis Sandra L,Ascher-Svanum Haya,Stensland Michael,Kinon Bruce J

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Reference63 articles.

1. Direct Costs of Schizophrenia in Italian Community Psychiatric Services

2. Some Aspects of the Cost of Schizophrenia in France

3. Measuring the Costs of Schizophrenia

4. Reliability, Validity, and Application of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) in Schizophrenic Patients Treated With Olanzapine Versus Haloperidol

5. The MOS 36-Item Short Form Health Survey

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database study;Journal of Medical Economics;2021-01-01

2. Hospitalization risk in bipolar disorder patients treated with lurasidone versus other atypical antipsychotics;Current Medical Research and Opinion;2018-04-22

3. Hospitalization outcomes in patients with schizophrenia after switching to lurasidone or quetiapine: a US claims database analysis;BMC Health Services Research;2018-04-04

4. A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis;Arthritis Research & Therapy;2017-07-20

5. Major depressive disorder with subthreshold hypomanic (mixed) features: A real-world assessment of treatment patterns and economic burden;Journal of Affective Disorders;2017-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3